Aptevo Therapeutics Inc.·4

Mar 5, 4:07 PM ET

Kwon SoYoung 4

4 · Aptevo Therapeutics Inc. · Filed Mar 5, 2024

Insider Transaction Report

Form 4
Period: 2024-03-02
Kwon SoYoung
SVP, GC, BD & Corp Affairs
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-02+3,66720,375 total
  • Exercise/Conversion

    Common Stock

    2024-03-03+3,66724,042 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-03-023,6677,333 total
    Common Stock (3,667 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-03-033,6673,667 total
    Common Stock (3,667 underlying)
Footnotes (3)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]On March 3, 2023, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
  • [F3]On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4